Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled date : 2021 - 10 - 14 source : Www.biospace.com save search
AGTC Announces Two Key Leadership Team Appointments- AGTC Welcomes Susan Schneider as the Chief Medical Officer and Sarah C. DiSalvatore as the Vice President of Clinical Operations -
Published: 2021-10-14 (Crawled : 23:00) - biospace.com/
OTIC | $0.077
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -4.98%
AGTC | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: 0.36%
H: 2.55%
C: -0.73%
Natus Medical Board of Directors Strengthens Governance and Focuses on Growth
Published: 2021-10-14 (Crawled : 23:00) - biospace.com/
NTUS | $32.96 0.09% 0.0%
|
Health Technology
|
| O: 0.54%
H: 1.97%
C: 1.64%
growth
White House Reportedly Vetting Former FDA Commissioner Califf for Role
Published: 2021-10-14 (Crawled : 23:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.32%
H: 0.9%
C: 0.25%
fda
First Wave BioPharma Announces Dosing of First Patient in Phase 2b Clinical Trial Evaluating Topical Niclosamide in Patients with Ulcerative Proctitis and Ulcerative Proctosigmoiditis
Published: 2021-10-14 (Crawled : 23:00) - biospace.com/
FWBI | $2.59 -8.8% -9.65% 83K
|
Manufacturing
|
| O: -1.01%
H: 0.0%
C: -2.38%
phase 2 biopharma phase 2b trial
Journey Biosciences and Cardinal Health OptiFreight® Logistics Collaborate to Improve Long-Term Diabetes Care
Published: 2021-10-14 (Crawled : 23:00) - biospace.com/
CAH | $108.19 2.07% 0.0% 1.5M
|
Distribution Services
|
| O: 1.34%
H: 0.63%
C: 0.52%
diabetes bioscience collaboration
Moderna Announces FDA Advisory Committee Unanimously Votes in Support of Emergency Use for a Booster Dose of Moderna’s COVID-19 Vaccine in the U.S.
Published: 2021-10-14 (Crawled : 22:00) - biospace.com/
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: 2.33%
H: 2.54%
C: 0.88%
covid fda vaccine merge
Aptar Declares Quarterly Dividend
Published: 2021-10-14 (Crawled : 22:00) - biospace.com/
ATR | $139.34 0.17% 0.0% 240K
|
Process Industries
|
| O: 0.09%
H: 0.67%
C: 0.39%
ImmunoGen Announces Conference Call to Discuss Its Third Quarter 2021 Operating Results
Published: 2021-10-14 (Crawled : 22:00) - biospace.com/
IMGN | $31.23 0.03% 49M
|
Health Technology
|
| O: 1.03%
H: 1.69%
C: -0.17%
results conference
Gilead Sciences to Release Third Quarter 2021 Financial Results on Thursday, October 28, 2021
Published: 2021-10-14 (Crawled : 22:00) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.86%
H: 0.76%
C: -0.09%
financial results results
LeMaitre Will Announce Third Quarter 2021 Earnings Results on October 28, 2021
Published: 2021-10-14 (Crawled : 22:00) - biospace.com/
LMAT | News | $63.23 0.97% 0.92% 160K
|
Health Technology
|
| O: 0.49%
H: 2.21%
C: 1.06%
results
AbCellera to Report Third Quarter 2021 Financial Results on November 9, 2021
Published: 2021-10-14 (Crawled : 22:00) - biospace.com/
ABCL | $3.88 -0.77% -0.77% 980K
|
|
| O: 0.39%
H: 5.07%
C: 2.12%
financial results results
Rhythm Pharmaceuticals Completes Submission of Type II Variation Application to the European Medicines Agency for IMCIVREE® (setmelanotide) for Bardet-Biedl and Alström Syndromes
Published: 2021-10-14 (Crawled : 21:00) - biospace.com/
RYTM A | $37.975 -0.35% -0.36% 620K
|
Health Technology
|
| O: 1.68%
H: 8.09%
C: 0.52%
europe submission setmelanotide obesity imcivree syndros
Movano Inc. to Report Third Quarter 2021 Financial Results on Thursday, November 11, 2021
Published: 2021-10-14 (Crawled : 21:00) - biospace.com/
MOVE | $0.484 -2.63% 26K
|
Manufacturing
|
| O: 0.0%
H: 1.29%
C: -1.48%
financial results results
White House Reportedly Vetting Former Commissioner Califf for Top Role
Published: 2021-10-14 (Crawled : 21:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.32%
H: 0.9%
C: 0.25%
Longeveron to Present at the 2021 Dawson James Securities 6th Annual Small Cap Growth Conference
Published: 2021-10-14 (Crawled : 20:00) - biospace.com/
LGVN 1 d | $1.93 -3.98% -4.15% 460K
|
|
| O: 6.56%
H: 4.43%
C: 0.99%
growth conference
Meridian Bioscience to Hold Fourth Quarter and Full Year 2021 Financial Results Conference Call on November 12, 2021
Published: 2021-10-14 (Crawled : 19:00) - biospace.com/
VIVO | $33.97 0.0% 0
|
Health Technology
|
| O: 0.81%
H: 1.02%
C: -1.18%
financial results results conference
PLx Pharma, Inc. Issues Statement on Recent USPTF Recommendations on Aspirin Therapy for Primary Prevention of Cardiovascular Disease
Published: 2021-10-14 (Crawled : 19:00) - biospace.com/
PLXP | $0.087 -4.6% 50M
|
Health Technology
|
| O: 0.12%
H: 1.04%
C: -16.83%
disease cardiovascular therapy cardio
Lilly Announces Updated Verzenio® (abemaciclib) Phase 3 monarchE Trial Data Presented at ESMO Virtual Plenary and Simultaneously Published in the Annals of Oncology
Published: 2021-10-14 (Crawled : 19:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.24%
H: 0.6%
C: -0.14%
phase 3 trial
Insights from the world's leading KOLs on the prospects of launched and pipeline therapies for non-small cell lung cancer
Published: 2021-10-14 (Crawled : 18:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.2%
H: 0.08%
C: -0.43%
lung cancer cancer therapy
Predictmedix Announces Form 20-F Registration Statement has Cleared SEC Comments
Published: 2021-10-14 (Crawled : 17:00) - biospace.com/
PMEDF | $0.0285 -5.13% 35K
|
Health Technology
|
| O: -0.29%
H: 0.0%
C: -1.48%
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.